Comorbid AR identifies a CRSwNP subgroup with marked tissue eosinophilia and increased risk of postoperative recurrence. It independently predicts earlier relapse and shorter recurrence-free survival, likely by amplifying local eosinophilic inflammation.
Zhong et al. (Tue,) studied this question.